Skip to content
Recall Observatory FDA recall evidence

Drug product

Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 00591-2720-60

D-0441-2023

February 22, 2023

Class II

Product summary

Firm
Teva Pharmaceuticals USA Inc
Event
Event 91744
Status
Terminated
Classification
Class II
Quantity
12,044 Bottles
Official record key
drug-enforcement:D-0441-2023

Official wording

Reason: CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Code information: Lot #: 1410946A; Exp. 06/2023

Distribution pattern: CA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations